PUBLISHER: The Business Research Company | PRODUCT CODE: 1390947
PUBLISHER: The Business Research Company | PRODUCT CODE: 1390947
“Agricultural Biologics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on agricultural biologics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for agricultural biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The agricultural biologics market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.
Agricultural biologicals play a crucial role in safeguarding plants against pests, enhancing yield, and preventing diseases. Derived from naturally occurring microorganisms, plant extracts, insects, or other organic matter, agricultural biologicals are integrated into crop protection practices to provide a holistic approach for growers. This approach aims to maximize crop yields, improve quality, and minimize pest resistance.
The primary types of agricultural biologicals include biopesticides, biofertilizers, and biostimulants. Biopesticides, derived from biological materials such as plants, animals, bacteria, and certain minerals, act as pesticides in agricultural applications. These biopesticides are sourced from microbials, macrobials, biochemicals, and other natural origins, and they are applied through foliar spray, soil treatment, seed treatment, and post-harvest modes. Applications of agricultural biologicals extend across various crops, including cereals and grains, oilseed and pulses, fruits and vegetables, as well as turf and ornamentals, and other agricultural applications.
The agricultural biologics market research report is one of a series of new reports from The Business Research Company that provides agricultural biologics market statistics, including agricultural biologics industry global market size, regional shares, competitors with an agricultural biologics market share, detailed agricultural biologics market segments, market trends and opportunities, and any further data you may need to thrive in the agricultural biologics industry. This agricultural biologics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The agricultural biologics market size has grown rapidly in recent years. It will grow from $12.39 in 2023 to $14.41 in 2024 at a compound annual growth rate (CAGR) of 16.3%. The growth observed in the historic period can be attributed to several factors, including the rise in organic farming practices, increased awareness of the environmental impact of chemical pesticides and fertilizers, the growth of the global population, and the emerging economic growth in various economies. These combined influences have played a significant role in shaping the positive trajectory witnessed during that time.
The agricultural biologics market size is expected to see rapid growth in the next few years. It will grow to $25.66 in 2028 at a compound annual growth rate (CAGR) of 15.5%. The anticipated growth in the forecast period can be attributed to various factors, including the increasing demand for food, favorable government policies, the need for higher crop yields, the adoption of precision agriculture practices, and a rise in disposable income. Key trends expected during this period encompass the development of customized microbial solutions, the application of biological seed treatments, the formulation of biodegradable biologic products, and the utilization of blockchain technology within the agricultural biologicals industry. These trends reflect the evolving landscape of agriculture and the industry's commitment to innovation, sustainability, and technological advancements.
The agricultural biologics market has experienced growth due to an increase in pest outbreaks, which indicate a rise in sporadic and large pest populations that cause economic harm to crops and humans. These outbreaks result in significant losses ranging between 10% and 40% of major food crops like corn, wheat, and rice, impacting the global economy. The damage caused by pests diminishes crop yields, posing a threat to food security and regional economies. For instance, a May 2023 article published by Springer Nature Limited estimated an annual crop yield loss of around US$220 billion caused by pathogens and pests, directly impacting food security and various socio-economic aspects. Therefore, the surge in pest outbreaks has driven the growth of the agricultural biologics market.
Increased investments in research and development (R&D) are expected to fuel the agricultural biologics market. These investments involve allocating resources to advance innovation and create new agricultural biologics that enhance quality, consistency, and cost-effectiveness. In 2021, the Bill & Melinda Gates Foundation pledged $10 million to support the development of biological tools and technologies aimed at addressing agricultural challenges in Sub-Saharan Africa. This commitment underlines the importance of R&D in creating solutions to agricultural issues. Therefore, the surge in investments in R&D is anticipated to drive the growth of the agricultural biologics market.
Strategic collaborations and partnerships are emerging as key trends in the agricultural biologics market. These partnerships among industry players are aimed at developing and commercializing agricultural biological products, benefiting growers and the businesses involved. For instance, in October 2021, UPL, an Indian bio-solutions manufacturer and distributor, announced a collaboration with Chr. Hansen, a Danish bioscience company, to help farmers globally combat pest diseases and enhance crop quality and yields. Additionally, in August 2021, Marrone Bio Innovations Inc., a US-based provider of sustainable protection and plant health solutions, partnered with Terramera, a Canadian agri-tech company, to combine their technological and biological expertise. This collaboration aims to improve the performance of MBI's crop protection products and expedite product development.
Key players in the agriculture biologics market are placing emphasis on the development of innovative products, such as the ENTAZIATM biofungicide, to fortify their market positions. ENTAZIATM is a biofungicide that can be integrated into FMC's biostimulants and synthetic fungicides within a comprehensive pest control strategy, delivering additional benefits to plants. For instance, in August 2023, FMC Corporation, an India-based agricultural sciences company, introduced ENTAZIATM, a revolutionary biological crop protection solution formulated around Bacillus subtilis. This advanced technology equips farmers with a potent, long-lasting tool for fungus protection while upholding environmental integrity. It not only safeguards farmers' productivity but also contributes to a more environmentally sustainable agricultural ecology, as exemplified by ENTAZIATM biofungicide.
In September 2023, Biobest Group NV, a Belgium-based producer of biological-based crop protection and pollination products, acquired Biotrop for $569.4 million. The acquisition aligns with Biobest's strategy to expand into South American markets, positioning itself as a major provider of biological solutions encompassing biocontrol, biostimulants, and other sustainable crop protection products. Biotrop, based in Brazil, specializes in natural and biological technologies for agricultural applications.
Major companies operating in the agricultural biologics market include Syngenta AG, Dow Chemical Company, Bayer AG, BASF SE, Isagro SPA, Corteva Inc., Marrone Bio Innovations Inc., Certis Group, Valent BioSciences Corp., BioWorks Inc., Andermatt Biocontrol AG, Koppert Biological Corp., Biowin AG, Verdesian Life Sciences LLC, Vestaron Corporation, Novozymes Biologicals AS, Gowan Company, AgBiome Inc., Sipcam Agro USA, Inocucor Technologies Inc., Biobest Group NV, NewLeaf Symbiotics Inc., Indigo Agriculture, Azotic Technologies, Lallemand Plant Care, Terramera Inc., FMC Corporation, Isagro Asia Pvt. Ltd., BioConsortia Inc., Valent USA LLC
North America was the largest region in the agricultural biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the agricultural biologics market. The regions covered in the agricultural biologics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the agricultural biologics market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The agricultural biologics market consists of sales of agricultural biologicals from sources such as plant extracts and minerals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.